Cardiovascular Complications of Prostate Cancer Treatment
This article provides a unique and comprehensive overview of the prevalence and possible mechanisms of cardiovascular toxicities of all PC therapies, including state-of-the-art antineoplastic agents. Additionally, this article summarizes available recommendations regarding screening and prevention of the most common cardiac complications among patients with advanced cancer disease.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Drugs & Pharmacology | Heart | Hormonal Therapy | Hormones | Immunotherapy | Prostate Cancer | Toxicology